Bibliometrics and visualization analysis of therapeutic drug monitoring based on Web of Science database
10.3760/cma.j.cn114015-20220324-00238
- VernacularTitle:基于WOS数据库的治疗药物监测文献计量和可视化分析
- Author:
Chen PAN
1
;
Mingnan CAO
;
Hang YIN
;
Ranjia LIU
;
Qiang HAN
;
Xiangli CUI
Author Information
1. 首都医科大学附属北京友谊医院药剂科，北京 100050
- Publication Type:Journal Article
- Keywords:
Therapeutic drug monitoring;
Inflammatory bowel disease;
Biological agents;
Anti-infective agents;
Antineoplastic agents;
Visualization analysis
- From:
Adverse Drug Reactions Journal
2022;24(11):591-598
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the international research hotpots and development trend of therapeutic drug monitoring (TDM).Methods:Web of Science database was searched as of February 16, 2022, with search term of "therapeutic drug monitoring" or "drug monitoring". The research articles on TDM were collected and analyzed for the annual publication amount, countries, authors, and institutions. Citation burst was detected using CiteSpace software, and keywords-cluster was carried out by VOSviewer to visually show the research hotpots.Results:A total of 2 318 articles were included, and the first one was published in 1975. The United States published the largest amount of related articles and had the closest cooperation with other countries. University of Queensland in Australia was the institution with the most publications, and Roberts JA was the author with the most publications. A total of 10 citation bursts were detected, and 6 keywords-clusters related to TDM were found by cluster analysis method. Recent international research hotspots included TDM of biologics in patients with inflammatory bowel disease, TDM of anti-infective drugs in critically ill patients, and TDM of anti-tumor drugs.Conclusions:Referring to the international research hotspots, TDM should be carried out for more drugs, such as infliximab, adalimumab, and imatinib, etc., to provide personalized and precise medication care for patients and improve the safety of drug therapy.
